The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations
- PMID: 18090342
- DOI: 10.1097/01.prs.0000248794.63898.0f
The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations
Abstract
Background: Bioengineered hyaluronic acid derivatives are currently available that provide for safe and effective soft-tissue augmentation in the comprehensive approach to nonsurgical facial rejuvenation. Current hyaluronic acid fillers do not require preinjection skin testing and produce reproducible, longer-lasting, nonpermanent results compared with other fillers, such as collagen.
Methods: A review of the authors' extensive experience at the University of Texas Southwestern Medical Center was conducted to formulate the salient requirements for successful utilization of hyaluronic acid fillers. Indications, technical refinements, and key components for optimized product administration categorized by anatomical location are described. The efficacy and longevity of results are also discussed.
Results: Bioengineered hyaluronic acid fillers allow for safe and effective augmentation of selected anatomical regions of the face, when properly administered. Combined treatment with botulinum toxin type A can enhance the effects and longevity by as much as 50 percent. Key components to optimal filler administration include proper anatomical evaluation, changing or combining various fillers based on particle size, altering the depth of injection, using different injection techniques, and coadministration of botulinum toxin type A when indicated. Concomitant administration of hyaluronic acid fillers along with surgical methods of facial rejuvenation can serve as a powerful tool in maximizing a comprehensive treatment plan.
Conclusions: Current techniques in nonsurgical facial rejuvenation and shaping with hyaluronic acid fillers are safe, effective, and long-lasting. Combination regimens that include surgical facial rejuvenation techniques and/or coadministration of botulinum toxin type A further optimize results, leading to greater patient satisfaction.
Similar articles
-
Hyaluronic acid-based fillers: theory and practice.Clin Dermatol. 2008 Mar-Apr;26(2):123-59. doi: 10.1016/j.clindermatol.2007.09.001. Clin Dermatol. 2008. PMID: 18472056
-
Hyaluronic acid fillers and botulinum toxin type a: rationale for their individual and combined use for injectable facial rejuvenation.Plast Reconstr Surg. 2007 Nov;120(6 Suppl):81S-88S. doi: 10.1097/01.prs.0000248857.84859.07. Plast Reconstr Surg. 2007. PMID: 18090346
-
Complications in fillers and Botox.Oral Maxillofac Surg Clin North Am. 2009 Feb;21(1):13-21, v. doi: 10.1016/j.coms.2008.11.001. Oral Maxillofac Surg Clin North Am. 2009. PMID: 19185791
-
Concomitant Use of Hyaluronic Acid and Laser in Facial Rejuvenation.Aesthetic Plast Surg. 2019 Aug;43(4):1061-1070. doi: 10.1007/s00266-019-01393-7. Epub 2019 May 9. Aesthetic Plast Surg. 2019. PMID: 31073742 Free PMC article. Review.
-
Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.Plast Reconstr Surg. 2008 May;121(5 Suppl):5S-30S. doi: 10.1097/PRS.0b013e31816de8d0. Plast Reconstr Surg. 2008. PMID: 18449026
Cited by
-
Comparative In Vivo Study of Solid-Type Pure Hyaluronic Acid in Thread Form: Safety and Efficacy Compared to Hyaluronic Acid Filler and Polydioxanone Threads.Aesthetic Plast Surg. 2024 Jan;48(2):221-227. doi: 10.1007/s00266-023-03614-6. Epub 2023 Aug 29. Aesthetic Plast Surg. 2024. PMID: 37644191 Free PMC article.
-
Hyaluronic acid injection to coronal sulcus of the penis for the treatment of premature ejaculation: a retrospective observational study.BMC Urol. 2023 Apr 1;23(1):55. doi: 10.1186/s12894-023-01214-9. BMC Urol. 2023. PMID: 37005592 Free PMC article.
-
Lyophilized Progenitor Tenocyte Extracts: Sterilizable Cytotherapeutic Derivatives with Antioxidant Properties and Hyaluronan Hydrogel Functionalization Effects.Antioxidants (Basel). 2023 Jan 10;12(1):163. doi: 10.3390/antiox12010163. Antioxidants (Basel). 2023. PMID: 36671025 Free PMC article.
-
Delayed Onset Nodules After Hyaluronic Acid Fillers: A Case Series.J Cutan Aesthet Surg. 2022 Jan-Mar;15(1):91-94. doi: 10.4103/JCAS.JCAS_200_20. J Cutan Aesthet Surg. 2022. PMID: 35655648 Free PMC article.
-
Safety in the Use of Fillers in Nasal Augmentation-the Liquid Rhinoplasty.Plast Reconstr Surg Glob Open. 2020 Aug 18;8(8):e2820. doi: 10.1097/GOX.0000000000002820. eCollection 2020 Aug. Plast Reconstr Surg Glob Open. 2020. PMID: 32983752 Free PMC article. No abstract available.
References
-
- Rohrich, R. J., Rios, J. L., and Fagien, S. Role of new fillers in facial rejuvenation: A cautious outlook. Plast. Reconstr. Surg. 112: 1899, 2003.
-
- Duranti, F., Salti, G., Bovani, B., et al. Injectable hyaluronic acid gel for soft tissue augmentation: A clinical and histological study. Dermatol. Surg. 24: 1317, 1998.
-
- Laurent, T. C. Biochemistry of hyaluronan. Acta Otolaryngol. Suppl. 442: 7, 1987.
-
- Devore, D. P., Hughes, E., and Scott, J. B. Effectiveness of injectable filler materials for smoothing wrinkle lines and depressed scars. Med. Prog. Technol. 20: 243, 1994.
-
- Longas, M. O., Russell, C. S., and He, X. Y. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr. Res. 159: 127, 1987.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources